The examination of the second-line chemotherapy in SCLC patients with interstitial lung disease

R. Ozaki (Tokushima, Japan), H. Nokihara (Tokushima, Japan), Y. Yabuki (Tokushima, Japan), A. Mitsuhashi (Tokushima, Japan), H. Yoneda (Tokushima, Japan), K. Otsuka (Tokushima, Japan), H. Ogino (Tokushima, Japan), Y. Nishioka (Tokushima, Japan)

Source: International Congress 2022 – Clinical problems in respiratory medicine: 1
Session: Clinical problems in respiratory medicine: 1
Session type: Thematic Poster
Number: 157

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Ozaki (Tokushima, Japan), H. Nokihara (Tokushima, Japan), Y. Yabuki (Tokushima, Japan), A. Mitsuhashi (Tokushima, Japan), H. Yoneda (Tokushima, Japan), K. Otsuka (Tokushima, Japan), H. Ogino (Tokushima, Japan), Y. Nishioka (Tokushima, Japan). The examination of the second-line chemotherapy in SCLC patients with interstitial lung disease. 157

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.